A clinical overview of cholinesterase inhibitors in Alzheimer's disease.
about
Pathways towards and away from Alzheimer's diseaseGene therapy in clinical medicineCognitive enhancement as a pharmacotherapy target for stimulant addictionCognitive function as an emerging treatment target for marijuana addictionCognitive enhancers in the treatment of substance use disorders: clinical evidence.Current and future treatments for Alzheimer's diseaseDisease-modifying treatments for Alzheimer's disease.Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer diseaseMental health care for the elderly in low-income countries: a health systems approach.Rivastigmine: a placebo controlled trial of twice daily and three times daily regimens in patients with Alzheimer's disease.Current concepts in therapeutic strategies targeting cognitive decline and disease modification in Alzheimer's disease.Cholinergic functioning in stimulant addiction: implications for medications development.A computational view on the significance of E-ring in binding of (+)-arisugacin A to acetylcholinesterase.(+)-Arisugacin A--computational evidence of a dual binding site covalent inhibitor of acetylcholinesterase.Cognitive-Enhancing Effect of a Hydroethanolic Extract of against Memory Impairment Induced by Aluminum Chloride in BALB/c Mice
P2860
Q24596270-02B45F3A-19F6-41FF-81B1-CEA86DF8C802Q24680275-E289CD8A-A790-4F12-8752-56205075CED5Q33599983-26F3F815-A5A5-4A86-B939-CACDC1961604Q34018386-AB49451F-90A9-4A29-B828-63D0BE0AD0ECQ34183988-64974D2E-64D2-488F-A640-539871C962F9Q34646921-814FF8EB-7CA6-4F1E-9CA9-C04152254F4AQ35090423-4AF8548A-F1E0-4273-B16D-240544A0AA2CQ35626834-59A06D77-F8B6-40BD-8EDA-F22F31A0B0D5Q35663651-DD694D17-3C8A-4FF5-A2AB-BDB751C68648Q36226630-66E1BE42-01AC-4254-9DF0-701563264B84Q36401406-2EC736AD-905A-4A47-88E0-AF731C18BEE8Q37618780-C61A32DB-F8ED-4142-8D5A-B7E187E2456CQ42148589-6F87F5FE-7984-4F15-AC61-DCD4A8CF89DDQ42721755-77D55F33-9A59-4D8B-A343-A20040D62B3EQ58583200-4DA14E74-44F3-48F5-A88A-DFA1789B31B3
P2860
A clinical overview of cholinesterase inhibitors in Alzheimer's disease.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
A clinical overview of cholinesterase inhibitors in Alzheimer's disease.
@ast
A clinical overview of cholinesterase inhibitors in Alzheimer's disease.
@en
type
label
A clinical overview of cholinesterase inhibitors in Alzheimer's disease.
@ast
A clinical overview of cholinesterase inhibitors in Alzheimer's disease.
@en
prefLabel
A clinical overview of cholinesterase inhibitors in Alzheimer's disease.
@ast
A clinical overview of cholinesterase inhibitors in Alzheimer's disease.
@en
P1476
A clinical overview of cholinesterase inhibitors in Alzheimer's disease
@en
P2093
Martin Farlow
P304
P478
14 Suppl 1
P577
2002-01-01T00:00:00Z